Analyst Ratings for Acceleron Pharma (XLRN) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/19/2021 | Wolfe Research | Andrew Galler | New Coverage | Outperform (N/A) |
183.00 (N/A) |
117.26 (178.75) |
52.44% | Details |
| 5/24/2019 | Citi » Updated 3/1/2021 |
Yigal Nochomovitz | New Coverage | Buy (N/A) |
171.00 (137.00) |
43.25 (178.75) |
313.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
